Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 101 related to Alleva: Immunological characterization and therapeutic activity of an altered-peptide ligand,.... (0.14 sec) 

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI- …


DG Alleva, A Gaur, L Jin, D Wegmann, PA … - Diabetes, 2002 - Am Diabetes Assoc
The nonobese diabetic (NOD) mouse is a good model for human type 1 diabetes,
which is characterized by autoreactive T-cell-mediated destruction of
insulin-producing islet β-cells of the pancreas. The 9–23 amino acid ...
Cited by 69 - Related articles - BL Direct - All 4 versions

Immunomodulation in Type 1 Diabetes by NBI-6024, an Altered Peptide Ligand of the Insulin …


DG Alleva, RA Maki, AL Putnam, JM Robinson … - Scandinavian Journal of Immunology, 2006 - interscience.wiley.com
NBI-6024 is an altered peptide ligand (APL) corresponding to the 9–23 amino
acid region of the insulin B chain (B (9−23) ), an epitope recognized by
inflammatory interferon-γ-producing T helper (Th)1 lymphocytes in type 1 ...
Cited by 20 - Related articles - BL Direct - All 6 versions

[CITATION] Peptide and MHC specific breaking of humoral tolerance to native insulin with the B: 9-23 …


N Abiru, AK Maniatis, L Yu, D Miao, H … - Diabetes, 2001
Cited by 29 - Related articles

Anti-peptide autoantibodies and fatal anaphylaxis in NOD mice in response to insulin self- …

- nih.gov
E Liu, H Moriyama, N Abiru, D Miao, L Yu, RM … - Journal of Clinical Investigation, 2002 - Am Soc Clin Investig
There is evidence that amino acids 9–23 of the insulin B chain are a major
target of anti-islet autoimmunity in type 1 diabetes. Administration of this
peptide to NOD mice prevents diabetes, and phase I trials of an altered ...
Cited by 56 - Related articles - BL Direct - All 8 versions

Evidence for a primary islet autoantigen (preproinsulin 1) for insulitis and diabetes in the …

- nih.gov
H Moriyama, N Abiru, J Paronen, K Sikora, E … - Proceedings of the National Academy of Sciences, 2003 - National Acad Sciences
It has been reported that an insulin 2 gene knockout, when bred onto nonobese
diabetic (NOD) mice, accelerates diabetes. We produced insulin 1 gene knockout
congenic NOD mice. In contrast to insulin 2, diabetes and insulitis were ...
Cited by 79 - Related articles - BL Direct - All 10 versions

Dual overlapping peptides recognized by insulin peptide B: 9–23 T cell receptor AV13S3 T …


N Abiru, D Wegmann, E Kawasaki, P Gottlieb, … - Journal of Autoimmunity, 2000 - Elsevier
T cells isolated from islets of non-obese diabetic (NOD) mice are enriched for
insulin-reactive cells. The great majority of these T cells recognize insulin B
chain peptide (B:9–23). B:9–23 reactive T cell clones are diabetogenic ...
Cited by 35 - Related articles - BL Direct - All 5 versions

Pancreatic β-cell function and immune responses to insulin after administration of intranasal …

- milray.org [PDF]  - Free from Publisher
LC Harrison, MC Honeyman, CE Steele, NL … - Diabetes Care, 2004 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—A total of 38 individuals, median age 10.8 years,
with antibodies to one or more pancreatic islet antigens (insulin, GAD65, or
tyrosine phosphatase-like insulinoma antigen 2) were randomized to ...
Cited by 33 - Related articles - BL Direct - All 8 versions

Induction and acceleration of insulitis/diabetes in mice with a viral mimic (polyinosinic- …

- pnas.org
H Moriyama, L Wen, N Abiru, E Liu, L Yu, D … - Proceedings of the National Academy of Sciences, 2002 - National Acad Sciences
Polyinosinic-polycytidylic acid (PolyIC), a “mimic” of double-stranded viral
RNA, can induce diabetes when administered to rats with RT1 u , and immunization
of normal H-2 d mice (eg, BALB/c) with insulin B:9–23 peptide (but not ...
Cited by 85 - Related articles - BL Direct - All 8 versions

Heat shock protein therapy fails to prevent diabetes in NOD mice


M Bowman, M Atkinson - Diabetologia, 2002 - Springer
In terms of therapeutic efficacy, no whole protein or peptide administered at 12
or 15 weeks of age altered the frequency of Type I diabetes (Fig. 1).
Specifically, there were no differences in the cumulative diabetes ...
Cited by 7 - Related articles - All 3 versions

[PDF] Recessive tolerance to preproinsulin 2 reduces but does not abolish type 1 diabetes


E Jaeckel, MA Lipes, H von Boehmer - Insulin (pmol/l) - microbio.uab.edu
Although autoimmune diseases can be initiated by immunization with a single
antigen, it is not clear whether a single self antigen is essential for the
initiation and, perhaps, the perpetuation of spontaneous autoimmunity. Some ...
Cited by 55 - Related articles - BL Direct - All 7 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google